Change - Announcement of Cessation::Resignation of Executive Director
Issuer & Securities
TRITECH GROUP LIMITED
TRITECH GROUP LIMITED - SG2G71000001 - 5G9
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Resignation of Executive Director
Submitted By (Co./ Ind. Name)
Dr Wang Xiaoning
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: email@example.com).
Name Of Person
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Due to recent developments in his personal circumstances, Dr Cai Jungang has elected to tender his resignation as a Director of the Company, such offer of resignation being strictly on a without prejudice and non admission of liability basis. Due to the unforeseen need for an immediate announcement, the Sponsor has yet to complete its interview with Dr Cai Jungang and will update Shareholders in due course.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
If Yes, Please provide full details
Please refer to the Company's announcement dated 24th July 2020.
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Role and responsibilities
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Direct and deemed interest in 62,401,805 Ordinary Shares in the Company.
Past (for the last 5 years)
1. Tritech Consultants Pte. Ltd.
2. Tritech Engineering & Testing (Singapore) Pte. Ltd.
3. Tritech Water Technologies Pte. Ltd.
4. Tritech SysEng Pte. Ltd.
5. Tritech (Qingdao) Membrane Industry Co. Ltd.
6. TGL Engineering Group Pte. Ltd.
7. Tritech Vavie (Qingdao) Healthcare Technologies Co. Ltd.